RankingsLogo

Cencora, Inc.

Cencora, Inc. is a Humankind 100 company whose ranking is based on its Humankind Value, a proprietary metric that provides an estimate of the overall dollar amount a company creates for investors, consumers, employees, and society at large.

Cencora, Inc. Is American drug wholesale company which provides distribution of brand name and generic pharmaceuticals as well as pharmaceutical consulting services.

Ticker: COR

Humankind Value: $37.3 B

Revenue: $222.5 B

Market Cap: $44.8 B

Badge100_2024
Positive and negative impacts of companies graphic.

(All values are in US Dollars, where M=Million, B=Billion, T=Trillion.)

Cencora, Inc. operates in a manner that is a net positive for humanity. The greatest contributors to this positive outcome are Healthcare R&D ($15.7 B), Pharmaceuticals ($8.3 B), and Medical Services ($7.5 B). The value associated with Healthcare R&D, Pharmaceuticals, and Medical Services is linked to an estimate of 610,000 additional years lived by people worldwide. The Humankind Value of this company can improve with reductions in Workplace Injuries (-$654.9 M) and Greenhouse Gases (-$234.7 M). Workplace Injuries is attached to this company as a result of its direct business activities. Healthcare R&D, Pharmaceuticals, Medical Services, and Greenhouse Gases are mostly or entirely a result of supply-chain relationships. While this company has a positive Humankind Value when studied in isolation, consideration of supply chain interactions pushes its Humankind Value higher.

How the Humankind Value Methodology Drives the Rankings

We take a quantitative, data-driven approach to estimating the economic impact that companies have on investors, customers, employees, and society at large, rolling social responsibility into a single dollar value that we use to represent what a company is contributing to humanity. As far as we can tell, we're the first ones doing it this way.

LEARN MORE ABOUT OUR RESEARCH
How Methodology Drives the Rankings